← Evidence map

TrialOrphanet journal of rare diseases2025

Early oxytocin treatment in infants with Prader-Willi syndrome is safe and is associated with better endocrine, metabolic and behavioral outcomes.

Marion Valette et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2025
2026
this papertrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 40025514